loadpatents
name:-0.077866077423096
name:-0.13761615753174
name:-0.00072813034057617
Boehm; Jeffrey C. Patent Filings

Boehm; Jeffrey C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boehm; Jeffrey C..The latest application filed is for "2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy".

Company Profile
0.24.22
  • Boehm; Jeffrey C. - King of Prussia PA
  • Boehm, Jeffrey C - King of Prussia PA
  • Boehm; Jeffrey C. -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
Grant 8,354,416 - Callahan , et al. January 15, 2
2013-01-15
Compounds
Grant 8,207,176 - Callahan , et al. June 26, 2
2012-06-26
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
Grant 8,058,282 - Adams , et al. November 15, 2
2011-11-15
2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one Compounds And Compositions For Use In Therapy
App 20110046109 - Adams; Jerry L. ;   et al.
2011-02-24
Novel Compounds
App 20110009625 - Adams; Jerry L. ;   et al.
2011-01-13
2,4,5-Trisubstituted pyrimidine compounds
Grant 7,759,486 - Adams , et al. July 20, 2
2010-07-20
Compounds
Grant 7,700,768 - Adams , et al. April 20, 2
2010-04-20
Compounds
Grant 7,678,801 - Callahan , et al. March 16, 2
2010-03-16
Tetrasubstituted pyrimidine compounds as chemical intermediates
Grant 7,629,462 - Adams , et al. December 8, 2
2009-12-08
Compounds
Grant 7,629,350 - Boehm , et al. December 8, 2
2009-12-08
Novel Compounds
App 20090156597 - Callahan; James F. ;   et al.
2009-06-18
Novel Compounds
App 20090137550 - Boehm; Jeffrey C. ;   et al.
2009-05-28
Novel Compounds
App 20090105478 - ADAMS; JERRY L. ;   et al.
2009-04-23
Novel Compounds
App 20090069318 - Callahan; James Francis ;   et al.
2009-03-12
Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives
App 20090048444 - Callahan; James F. ;   et al.
2009-02-19
Novel compounds
App 20090048442 - Adams; Jerry L. ;   et al.
2009-02-19
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
Grant 7,479,558 - Callahan , et al. January 20, 2
2009-01-20
Novel Compounds
App 20090005401 - Boehm; Jeffrey C. ;   et al.
2009-01-01
Compounds
Grant 7,423,042 - Boehm , et al. September 9, 2
2008-09-09
Process For Preparing Pyrido[2,3-D]Pyrimidin-7-One And 3,4-Dihydropyrimido{4,5-D}Pyrimidin-2(1H)-One Derivatives
App 20080096905 - Callahan; James Francis ;   et al.
2008-04-24
Novel Compounds
App 20080033170 - Adams; Jerry L. ;   et al.
2008-02-07
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
Grant 7,323,472 - Adams , et al. January 29, 2
2008-01-29
2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
Grant 7,314,881 - Adams , et al. January 1, 2
2008-01-01
4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates
Grant 7,314,934 - Adams , et al. January 1, 2
2008-01-01
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one Compounds And Their Use In Treating Csbp/p38 Kinase Mediated Diseases
App 20070238743 - Adams; Jerry L. ;   et al.
2007-10-11
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one Compounds And Their Use In Treating Csbp/p38 Kinase Mediated Diseases
App 20070167467 - Adams; Jerry L. ;   et al.
2007-07-19
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
Grant 7,235,551 - Adams , et al. June 26, 2
2007-06-26
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
App 20060258687 - Boehm; Jeffrey C. ;   et al.
2006-11-16
Novel compounds
App 20060235029 - Callahan; James F. ;   et al.
2006-10-19
Novel compounds
App 20060217401 - Boehm; Jeffrey C. ;   et al.
2006-09-28
3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors
Grant 7,053,098 - Adams , et al. May 30, 2
2006-05-30
3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
Grant 6,982,270 - Adams , et al. January 3, 2
2006-01-03
Novel compounds
App 20050288503 - Adams, Jerry Leroy ;   et al.
2005-12-29
Novel Compounds
App 20050203109 - Adams, Jerry L. ;   et al.
2005-09-15
Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines
Grant 6,861,417 - Adams , et al. March 1, 2
2005-03-01
Novel compounds
App 20040209901 - Adams, Jerry L. ;   et al.
2004-10-21
Novel compounds
App 20040116697 - Adams, Jerry L. ;   et al.
2004-06-17
Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines
App 20040014973 - Adams, Jerry L. ;   et al.
2004-01-22
1,5- disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
App 20030100756 - Adams, Jerry L ;   et al.
2003-05-29
Substituted imidazole compounds
Grant 6,046,208 - Adams , et al. April 4, 2
2000-04-04
Substituted imidazole compounds
Grant 5,977,103 - Adams , et al. November 2, 1
1999-11-02
Substituted imidazole compounds
Grant 5,756,499 - Adams , et al. May 26, 1
1998-05-26
Substituted imidazole compounds
Grant 5,716,955 - Adams , et al. February 10, 1
1998-02-10
Imidazole compounds, use and process of making
Grant 5,593,991 - Adams , et al. January 14, 1
1997-01-14
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
Grant 5,004,758 - Boehm , et al. April 2, 1
1991-04-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed